Rakuten Aspyrian Closes $284 Million Series C Financing for Late-Stage Oncology Pipeline
Medical Health News,
, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoimmunotherapy platform…
, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoimmunotherapy platform…
SAN FRANCISCO, Dec. 21, 2018 /PRNewswire/ -- Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer…
SAN FRANCISCO, Dec. 20, 2018 /PRNewswire/ -- Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer…
SOURCE Rakuten Aspyrian, Inc. SAN FRANCISCO "My unwavering confidence in the vision and potential of Rakuten Aspyrian's…